Safety and tolerability of once-daily tiotropium Respimat® as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysis

Thumbnail
URI
http://hdl.handle.net/11287/617154
Author
Dahl, R.
Engel, M.
Dusser, D.
Halpin, David M
Kerstjens, H.A.M.
Zaremba-Pechmann, L.
Moroni-Zentgraf, P.
Busse, W. W.
Bateman, E. D.
Date
2016-07-02
Journal
Respiratory Medicine
Type
Journal Article
Publisher
Elsevier
DOI
10.1016/j.rmed.2016.07.001
Rights
Archived with thanks to Respiratory Medicine
Metadata
Show full item record
Citation
Safety and tolerability of once-daily tiotropium Respimat® as add-on to at least inhaled corticosteroids in adult patients with symptomatic asthma: A pooled safety analysis 2016 Sep;118:102-11
Publisher URL
http://linkinghub.elsevier.com/retrieve/pii/S0954611116301482
Collections